Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Geroscience ; 46(1): 71-85, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37646904

ABSTRACT

Alzheimer's disease (AD) is a progressive neurodegenerative disorder and is the most common cause of dementia. The pathogenesis of AD still remains unclear, including two main hypotheses: amyloid cascade and tau hyperphosphorylation. The hallmark neuropathological changes of AD are extracellular deposits of amyloid-ß (Aß) plaques and intracellular neurofibrillary tangles (NFTs). Endocytosis plays an important role in a number of cellular processes including communication with the extracellular environment, nutrient uptake, and signaling by the cell surface receptors. Based on the results of genetic and biochemical studies, there is a link between neuronal endosomal function and AD pathology. Taking this into account, we can state that in the results of previous research, endolysosomal abnormality is an important cause of neuronal lesions in the brain. Endocytosis is a central pathway involved in the regulation of the degradation of amyloidogenic components. The results of the studies suggest that a correlation between alteration in the endocytosis process and associated protein expression progresses AD. In this article, we discuss the current knowledge about endosomal abnormalities in AD.


Subject(s)
Alzheimer Disease , Humans , Alzheimer Disease/genetics , Amyloid beta-Protein Precursor/genetics , Amyloid beta-Protein Precursor/metabolism , Amyloid beta-Peptides/metabolism , Neurofibrillary Tangles/metabolism , Neurofibrillary Tangles/pathology , Endocytosis
2.
Arch Immunol Ther Exp (Warsz) ; 68(6): 35, 2020 Nov 13.
Article in English | MEDLINE | ID: mdl-33185755

ABSTRACT

The COVID-19 pandemic developing rapidly in 2020 is triggered by the emergence of a new human virus-SARS-CoV-2. The emergence of a new virus is not an unexpected phenomenon and has been predicted for many years. Since the virus has spread all over the world, it will be very difficult or even impossible to eradicate it. A necessary condition for complete or partial elimination of the virus is to have an effective vaccine. It is possible that SARS-CoV-2 will become milder in the next few years and COVID-19 will then only threaten individuals from risk groups.


Subject(s)
Betacoronavirus/physiology , Coronavirus Infections/epidemiology , Pandemics , Pneumonia, Viral/epidemiology , Animals , Betacoronavirus/pathogenicity , Biological Evolution , COVID-19 , Communicable Disease Control/organization & administration , Communicable Diseases, Emerging , Coronaviridae/genetics , Coronaviridae/pathogenicity , Coronavirus Infections/transmission , Coronavirus Infections/veterinary , Coronavirus Infections/virology , Disease Eradication , Disease Susceptibility , Forecasting , Host Specificity , Humans , Pandemics/prevention & control , Pneumonia, Viral/transmission , Pneumonia, Viral/virology , SARS-CoV-2 , Selection, Genetic , Virulence , Zoonoses
3.
J Innate Immun ; 10(2): 131-144, 2018.
Article in English | MEDLINE | ID: mdl-29306950

ABSTRACT

BACKGROUND: Oncolytic vesicular stomatitis virus (VSV) can be delivered intravenously to target primary and metastatic lesions, but the interaction between human peripheral blood leukocytes (PBLs) and VSV remains poorly understood. Our study aimed to assess the overall immunological consequences of ex vivo infection of PBLs with VSV. METHODS: Phenotypic analysis of lymphocyte subsets and apoptosis were evaluated with flow cytometry. Caspase 3/7 activity was detected by luminescence assay. Virus release was evaluated in a murine cell line (L929). Gene expression and cytokine/chemokine secretion were assessed by real-time PCR and multiplex assay, respectively. RESULTS: Ex vivo infection of PBLs with VSV elicited upregulated expression of RIG-I, MDA-5, tetherin, IFITM3, and MxA. VSV infection triggered rapid differentiation of blood monocytes into immature dendritic cells as well as their apoptosis, which depended on caspase 3/7 activation. Monocyte differentiation required infectious VSV, but loss of CD14+ cells was also associated with the presence of a cytokine/chemokine milieu produced in response to VSV infection. CONCLUSIONS: Systemic delivery is a major goal in the field of oncolytic viruses. Our results shed further light on immune mechanisms in response to VSV infection and the underlying VSV-PBL interactions bringing hope for improved cancer immunotherapies, particularly those based on intravenous delivery of oncolytic VSV.


Subject(s)
Leukocytes, Mononuclear/virology , Oncolytic Viruses/immunology , Vesicular stomatitis Indiana virus/immunology , Animals , Apoptosis , Caspases, Effector/metabolism , Cell Differentiation , Cell Line , Cytokines/metabolism , Dendritic Cells , Fibroblasts/virology , Healthy Volunteers , Humans , Leukocytes, Mononuclear/cytology , Leukocytes, Mononuclear/metabolism , Leukocytes, Mononuclear/pathology , Lipopolysaccharide Receptors/metabolism , Mice , Virus Replication
4.
Molecules ; 22(6)2017 Jun 12.
Article in English | MEDLINE | ID: mdl-28604620

ABSTRACT

A reaction of bis[(2-chlorocarbonyl)phenyl] diselenide with various mono and bisnucleophiles such as aminophenols, phenols, and amines have been studied as a convenient general route to a series of new antimicrobial and antiviral diphenyl diselenides. The compounds, particularly bis[2-(hydroxyphenylcarbamoyl)]phenyl diselenides and reference benzisoselenazol-3(2H)-ones, exhibited high antimicrobial activity against Gram-positive bacterial species (Enterococcus spp., Staphylococcus spp.), and some compounds were also active against Gram-negative E. coli and fungi (Candida spp., A.niger). The majority of compounds demonstrated high activity against human herpes virus type 1 (HHV-1) and moderate activity against encephalomyocarditis virus (EMCV), while they were generally inactive against vesicular stomatitis virus (VSV).


Subject(s)
Anti-Infective Agents/pharmacology , Antifungal Agents/pharmacology , Antiviral Agents/pharmacology , Benzene Derivatives/pharmacology , Organoselenium Compounds/pharmacology , Amines/chemical synthesis , Amines/chemistry , Aminophenols/chemical synthesis , Aminophenols/chemistry , Anti-Infective Agents/chemical synthesis , Anti-Infective Agents/chemistry , Antifungal Agents/chemical synthesis , Antifungal Agents/chemistry , Antioxidants/chemical synthesis , Antioxidants/chemistry , Antiviral Agents/chemical synthesis , Antiviral Agents/chemistry , Benzene Derivatives/chemical synthesis , Benzene Derivatives/chemistry , Candida/drug effects , Candida/pathogenicity , Escherichia coli/drug effects , Escherichia coli/pathogenicity , Herpesvirus 1, Human/drug effects , Herpesvirus 1, Human/pathogenicity , Humans , Microbial Sensitivity Tests , Organoselenium Compounds/chemical synthesis , Organoselenium Compounds/chemistry , Phenols/chemical synthesis , Phenols/chemistry
5.
Immunogenetics ; 68(5): 327-37, 2016 May.
Article in English | MEDLINE | ID: mdl-26888639

ABSTRACT

Killer cell immunoglobulin-like receptors (KIR) are the most polymorphic receptors of natural killer (NK) cells. Their activity diversifies the functions of NK cells in the antiviral immune response, so the presence of certain KIR may affect transmission of HIV-1. The aim of the study was to evaluate the influence of KIR genes on the susceptibility to HIV-1 infection in the Polish population depending on the route of exposure. We determined the frequencies of activating (2DS1, 2DS2, 2DS3, 2DS4f, 2DS4del, 2DS5, 3DS1) and inhibitory (2DL1, 2DL2, 2DL3, 2DL5, 3DL1) KIRs in HIV-1-positive patients (n = 459), individuals exposed to HIV-1 but uninfected (EU, n = 118) and in uninfected, healthy blood donors (BD, n = 98). Analysis was performed using stepwise logistic regression. Apart from KIRs, CCR5-∆32, and CCR2-64I, alleles were also analyzed, as we knew or suspected that these features could affect susceptibility to HIV infection. The regression confirmed the protective effect of CCR5-∆32 (OR = 0.25, p = 0.006) and CCR2-64I (OR = 0.59, p = 0.032) against HIV infection. Among KIR genes, 2DL3 was found to be a protective factor (OR = 0.30, p = 0.015). A similar effect was seen for 3DS1 but only in intravenous drug users (IDUs) (OR = 0.30, p = 0.019), not in sexually exposed people. 2DL5 was found to be a factor facilitating HIV infection (OR = 2.13, p = 0.013). A similar effect was observed for 2DL2 but only in females (OR = 2.15, p = 0.040), and 2DS1 in IDUs (OR = 3.03, p = 0.022). Our results suggest a beneficial role of KIR3DS1 and 2DL3 supporting resistance to HIV infection and a harmful effect of 2DS1, 2DL5, and 2DL2 genes promoting HIV acquisition.


Subject(s)
Disease Susceptibility , HIV Infections/genetics , HIV-1/genetics , Polymorphism, Genetic/genetics , Receptors, KIR/genetics , Adult , Case-Control Studies , Female , Gene Frequency , Genotype , HIV Infections/epidemiology , HIV Infections/virology , Humans , Killer Cells, Natural/metabolism , Male , Poland/epidemiology , Receptors, KIR3DL1/genetics , Receptors, KIR3DL2/genetics , Receptors, KIR3DS1/genetics
6.
Int J Oncol ; 48(2): 493-505, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26648160

ABSTRACT

The present study shows that an application of cyclophosphamide (CY) supported by dendritic cell (DC)-based vaccines affected differentiation of the activity of CD4+ T cell subpopulations accompanied by an alteration in CD8+ cell number. Vaccines were composed of bone marrow-derived DCs activated with tumor cell lysate (BM-DC/TAgTNF-α) and/or genetically modified DCs of JAWS II line (JAWS II/Neo or JAWS II/IL-2 cells). Compared to untreated or CY-treated mice, the combined treatment of MC38 colon carcinoma-bearing mice resulted in significant tumor growth inhibition associated with an increase in influx of CD4+ and CD8+ T cells into tumor tissue. Whereas, the division of these cell population in spleen was not observed. Depending on the nature of DC-based vaccines and number of their applications, both tumor infiltrating cells and spleen cells were able to produce various amount of IFN-γ, IL-4 and IL-10 after mitogenic ex vivo stimulation. The administration of CY followed by BM-DC/TAgTNF-α and genetically modified JAWS II cells, increased the percentage of CD4+T-bet+ and CD4+GATA3+ cells and decreased the percentage of CD4+RORγt+ and CD4+FoxP3+ lymphocytes. However, the most intensive response against tumor was noted after the ternary treatment with CY + BM-DC/TAgTNF-α + JAWS II/IL-2 cells. Thus, the administration of various DC-based vaccines was responsible for generation of the diversified antitumor response. These findings demonstrate that the determination of the size of particular CD4+ T cell subpopulations may become a prognostic factor and be the basis for future development of anticancer therapy.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Cancer Vaccines/immunology , Colonic Neoplasms/drug therapy , Colonic Neoplasms/immunology , Cyclophosphamide/pharmacology , Dendritic Cells/immunology , Animals , Antigens, Neoplasm/immunology , CD8-Positive T-Lymphocytes/immunology , Colonic Neoplasms/metabolism , Female , Immunotherapy, Adoptive/methods , Interferon-gamma/metabolism , Interleukin-10/metabolism , Interleukin-2/metabolism , Interleukin-4/metabolism , Mice , Mice, Inbred C57BL , Spleen/drug effects , Spleen/immunology , Spleen/metabolism
7.
Arch Immunol Ther Exp (Warsz) ; 64(1): 65-73, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26206121

ABSTRACT

Natural killer cells play an important role as effectors of innate immunity and regulators of adaptive immunity. They are important elements of the innate response to viral infections, which they detect using human leukocyte antigen (HLA) class I-binding receptors. Most polymorphic of these are killer cell immunoglobulin-like receptors (KIRs) which exist as two basic isotypes, activating or inhibitory receptors and are encoded by genes distributed differently in unrelated individuals. We searched for links between selected clinical data (including HCV viremia, liver enzymes level and liver histology parameters) and the presence of genes encoding these receptors and their ligands in hepatitis C virus-infected individuals subjected to pegylated interferon-α and ribavirin therapy. Genomic DNA samples from two hundred and ninety-two chronically infected patients were typed by polymerase chain reaction for the presence or absence of genes for KIRs and their ligands, class I HLA molecules, and clinical data of the patients were collected. Our results suggest an importance of clinical parameters and the contribution of KIR and HLA genes to the course of hepatitis C virus infection and the response to therapy. The study revealed that levels of liver enzymes before therapy were about 30% higher in patients who possessed a variant KIR2DS4 gene with 22-base pair deletion. Decrease of ALT activity after treatment was higher in HLA-C C2-positive than negative individuals. Beside it, patients demonstrated early virologic response to the therapy if the time lag before treatment was short, particularly in women.


Subject(s)
HLA-C Antigens/genetics , Hepacivirus/physiology , Hepatitis C, Chronic/immunology , Immunotherapy/methods , Killer Cells, Natural/immunology , Liver/physiology , Mutation/genetics , Receptors, KIR/genetics , Adult , Biomarkers, Pharmacological/metabolism , Female , Genetic Association Studies , Genetic Predisposition to Disease , Hepacivirus/drug effects , Hepatitis C, Chronic/therapy , Humans , Immunity, Innate/drug effects , Interferon-alpha/administration & dosage , Killer Cells, Natural/drug effects , Killer Cells, Natural/virology , Liver/drug effects , Liver/virology , Male , Middle Aged , Polymorphism, Genetic , Ribavirin/administration & dosage
8.
J Immunother ; 37(9): 427-39, 2014.
Article in English | MEDLINE | ID: mdl-25304726

ABSTRACT

A hostile tumor microenvironment, characterized by an abundance of T regulatory cells and myeloid-derived suppressor cells (MDSCs), considerably limits the efficacy of dendritic cell (DC)-based vaccines. The intention of this study was to enhance the antitumor activity of vaccines consisting of bone marrow-derived DCs stimulated with TAg (BMDC/TAg) via single administration of cyclophosphamide and multiple injections of interleukin (IL)-12-transduced DCs (BMDC/IL-12). The combined chemoimmunotherapy was applied in the treatment of mice with subcutaneously (SC) growing, advanced MC38 colon carcinoma. The highest level of tumor growth inhibition, accompanied by high cytotoxic activity of effector cells, and their increased influx into tumor tissue, was observed after application of cyclophosphamide in combination with BMDC/TAg and BMDC/IL-12. The effect was probably associated with the elimination of T regulatory cells from spleens and tumors, but most of all with changes in the number and differentiation stage of MDSCs. After the therapy, the percentage of granulocytic and monocytic MDSCs in spleens was significantly lower than in the control group. Moreover, MDSCs derived from spleens and tumors showed increased expression of MHC class II, which may indicate the higher maturation stage of the myeloid cells as well as their enhanced capacity toward antigen presentation. The obtained data indicate that the optimal composition of antitumor vaccines able to limit the suppressor activity of MDSCs is essential to enhance the elimination of tumor cells and to achieve an optimal therapeutic effect.


Subject(s)
Antigens, Neoplasm/immunology , Cancer Vaccines , Colonic Neoplasms/therapy , Cyclophosphamide/therapeutic use , Cytokines/genetics , Dendritic Cells/immunology , Animals , Cell Line, Tumor , Cell- and Tissue-Based Therapy , Colonic Neoplasms/drug therapy , Colonic Neoplasms/immunology , Colonic Neoplasms/pathology , Cytokines/immunology , Dendritic Cells/transplantation , Female , Immunotherapy , Mice, Inbred C57BL , Myeloid Cells/immunology , Spleen/cytology , Spleen/drug effects , Spleen/immunology , T-Lymphocytes, Regulatory/immunology , Transduction, Genetic , Tumor Burden/drug effects
9.
PLoS One ; 8(10): e77820, 2013.
Article in English | MEDLINE | ID: mdl-24204983

ABSTRACT

BACKGROUND: The human genome contains about 8% of endogenous retroviral sequences originated from germ cell infections by exogenous retroviruses during evolution. Most of those sequences are inactive because of accumulation of mutations but some of them are still capable to be transcribed and translated. The latter are insertionally polymorphic HERV-K113 and HERV-K115. It has been suggested that their presence and expression was connected with several human diseases. It is also believed that they could interfere with the replication cycle of exogenous retroviruses, including HIV. RESULTS: Prevalence of endogenous retroviral sequences HERV-K113 and HERV-K115 was determined in the Polish population. The frequencies were found as 11.8% for HERV-K113 and 7.92% for HERV-K115. To verify the hypothesis that the presence of these HERVs sequences could affect susceptibility to HIV infection, comparison of a control group (HIV-negative, not exposed to HIV; n = 303) with HIV-positive patients (n = 470) and exposed but uninfected (EU) individuals (n = 121) was performed. Prevalence of HERV-K113 and HERV-K115 in the EU group was 8.26% and 5.71%, respectively. In the HIV(+) group we detected HERV-K113 sequences in 12.98% of the individuals and HERV-K115 sequences in 7.23% of the individuals. There were no statistically significant differences between groups studied. CONCLUSION: The frequency of HERV-K113 and HERV-K115 sequences in Poland were found to be higher than usually shown for European populations. No relation between presence of the HERVs and HIV infection was detected.


Subject(s)
Endogenous Retroviruses/genetics , HIV Infections/epidemiology , HIV Infections/virology , HIV/genetics , Polymorphism, Genetic/genetics , Adolescent , Adult , Aged , Case-Control Studies , Child , Child, Preschool , DNA, Viral/genetics , Female , Follow-Up Studies , HIV Infections/genetics , Humans , Male , Middle Aged , Poland/epidemiology , Polymerase Chain Reaction , Prognosis , Young Adult
10.
AIDS Res Hum Retroviruses ; 29(1): 54-60, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22957692

ABSTRACT

Effects of chemokine receptor alleles (CCR5-Δ32 and CCR2-64I) on susceptibility to human immunodeficiency virus (HIV) infection were studied in a Polish population. The CCR5 and CCR2 genotypes were determined for 311 healthy, HIV-negative individuals (control group), 121 exposed to HIV infection but uninfected (EU group), and 470 HIV-positive patients. The frequency of the alleles in the control group was calculated as 0.12 for both CCR5-Δ32 and CCR2-64I. The logistic regression method was used to analyze the effects of the described factors. A protective effect was observed for the CCR5-Δ32 allele but only in the case of heterosexual exposure. Prevalence of the CCR5-Δ32/+ genotype in HIV(+) patients infected via the heterosexual route (n=61; 8.2%) was much lower than in the control group (n=311; 21.5%); in the heterosexually exposed uninfected group it was slightly higher (n=28; 25%). This suggested that in this mode of infection, the native CCR5 expression level was crucial for establishment of infection. Individuals with the CCR5-Δ32 allele have more than three times less chance of infection in the case of HIV heterosexual exposure (odds ratio, 3.37; 95% confidence interval, 1.055-10.76). However, a protective effect of the CCR5-Δ32/+ genotype was not observed in the case of intravenous drug users (IDUs). The rates of the genotype were similar in HIV-infected IDU individuals (n=356; 17.7%) and in exposed uninfected patients (n=84; 15.5%), not significantly different from control group. No effect of the CCR2 genotype was observed. The analysis revealed that the important factor increasing infection risk was, in particular, hepatitis C virus (HCV) infection (odds ratio, 12.9). Moreover, the effect of HCV infection was found to be age dependent. Susceptibility to HIV infection resulting from HCV positivity became weaker (6% per year) with increasing age.


Subject(s)
HIV Infections/immunology , Receptors, CCR5/immunology , Adolescent , Adult , Age Factors , Aged , Alleles , Case-Control Studies , Child , Child, Preschool , Disease Susceptibility , Female , Gene Frequency , Genotype , HIV Infections/etiology , HIV Infections/transmission , HIV Seropositivity/genetics , HIV Seropositivity/immunology , Heterosexuality , Humans , Logistic Models , Male , Middle Aged , Poland/epidemiology , Polymorphism, Restriction Fragment Length/genetics , Receptors, CCR2/genetics , Receptors, CCR2/immunology , Receptors, CCR5/genetics , Substance Abuse, Intravenous/complications , Young Adult
11.
Folia Histochem Cytobiol ; 50(3): 414-9, 2012 Oct 08.
Article in English | MEDLINE | ID: mdl-23042272

ABSTRACT

Interleukin (IL-) 2 acts on a number of types of immune cells promoting their effector functions. To replace systemic administration of recombinant form of this cytokine, various genetically modified cells have been used indifferent preclinical models for tumor growth inhibition. In this study, dendritic or tumor cells transduced with retroviral vector carrying IL-2 gene (JAWS II/IL-2, X63/IL-2, MC38/IL-2 cells) alone or combined with tumor antigen-stimulated dendritic cells (JAWS II/TAg) were exploited to treat colon carcinoma MC38-bearing mice. After the peritumoral injection of vaccine cells, the tumor growth delay and the increase in the number of tumor infiltrating CD4⁺ and CD8⁺ T lymphocytes were noted. A considerable increase in CD4⁺ cell influx into tumor tissue was observed when JAWS II/IL-2 cells or JAWS II/TAg with syngeneic MC38/IL-2 cells were applied. The increase in intensity of CD8⁺ cell infiltration was associated with immune reaction triggered by the same combination of applied cells or JAWS II/TAg with allogeneic X63/IL-2 cells. The effect observed in vivo was accompanied by MC38/0 cell specific cytotoxic activity of spleen cells in vitro. Thus, the application of vaccines, including IL-2-secreting cells of various origins, was able to induce different antitumor responses polarized by exogenous IL-2 and the encountered tumor antigen.


Subject(s)
Colonic Neoplasms/immunology , Dendritic Cells/immunology , Interleukin-2/genetics , Transduction, Genetic , Animals , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Cancer Vaccines/immunology , Cell Death , Cell Line, Tumor , Cell Proliferation , Female , Mice , Mice, Inbred C57BL , Spleen/immunology
12.
Viral Immunol ; 23(6): 567-76, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21142442

ABSTRACT

The replication of vesicular stomatitis virus (VSV) in isolated human leukocytes has been used to measure the level of nonspecific antiviral immunity. However, during infection with some pathogens, the main effect observed is caused by interaction between the pathogen and VSV. This was also noted in advanced stages of HIV infection, when an inverse association between HIV viral load and VSV replication was found. The mutual effect was markedly stronger than the correlation between the VSV replication level and CD4(+) T-cell count. Since successful antiretroviral therapy is associated with a decrease in HIV viremia to undetectable levels, the effect of such therapy on VSV replication was expected and confirmed in this investigation. In fact, increased VSV titers were observed together with decreased HIV viral load, particularly in the case of efficient therapeutic schemes, for example those including lopinavir/ritonavir. The results showed that VSV replication capacity reflected the progression of HIV infection. Moreover, the presence of interferon in the plasma of AIDS patients was found to be only partially responsible for the inhibition of VSV replication. The results suggest a specific HIV-VSV interaction, whether direct or indirect. Thus the VSV replication assay may be applied in evaluating the stage of HIV infection.


Subject(s)
HIV Infections/immunology , HIV-1 , Vesicular stomatitis Indiana virus/physiology , Virus Replication/immunology , Adult , Antiretroviral Therapy, Highly Active , CD4 Lymphocyte Count , Cell Culture Techniques , Cell Line, Tumor , Female , HIV Infections/drug therapy , Humans , Interferons/blood , Male , Middle Aged , Viral Load
13.
Molecules ; 15(11): 8214-28, 2010 Nov 12.
Article in English | MEDLINE | ID: mdl-21076388

ABSTRACT

Various N-substituted benzisoselenazol-3(2H)-ones and their non-selenium-containing analogues have been synthesized and tested against selected viruses (HHV-1, EMCV and VSV) to determine the extent to which selenium plays a role in antiviral activity. The data presented here show that the presence of selenium is crucial for the antiviral properties of benzisoselenazol-3(2H)-ones since their isostructural analogues having different groups but lacking selenium either did not show any antiviral activity or their activity was substantially lower. The open-chain analogues of benzisoselenazol-3(2H)-ones--diselenides also exhibited high antiviral activity while selenides and disulfides were completely inactive towards model viruses.


Subject(s)
Antiviral Agents/chemistry , Antiviral Agents/pharmacology , Organoselenium Compounds/chemistry , Organoselenium Compounds/pharmacology , Selenium/chemistry , Antiviral Agents/chemical synthesis , Azoles/chemistry , Cell Line, Tumor , Humans , Isoindoles , Magnetic Resonance Spectroscopy , Molecular Structure , Organoselenium Compounds/chemical synthesis , Structure-Activity Relationship , Sulfur Compounds/chemical synthesis , Sulfur Compounds/chemistry , Sulfur Compounds/pharmacology , Viruses/drug effects
14.
Chem Pharm Bull (Tokyo) ; 56(10): 1423-7, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18827382

ABSTRACT

Different N-substituted benzisoselenazol-3(2H)-ones, analogues of ebselen were designed as new antiviral and antimicrobial agents. We report their synthesis, chemical properties as well as study on biological activity against broad spectrum of pathogenic microorganisms (Staphylococcus aureus, Staphylococcus simulans, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Candida albicans, Aspergillus niger) and viruses (herpes simplex virus type 1 (HSV-1), encephalomyocarditis virus (EMCV), vesicular stomatitis virus (VSV)), in vitro. Most of them exhibited high activity against viruses (HSV-1, EMCV) and gram-positive bacteria strains (S. aureus, S. simulans), while their activity against gram-negative bacteria strains (E. coli, P. aeruginosa, K. pneumoniae) was substantially lower. Some of tested compounds were active against yeast C. albicans and filamentous fungus A. niger.


Subject(s)
Anti-Infective Agents/chemical synthesis , Anti-Infective Agents/pharmacology , Bridged Bicyclo Compounds, Heterocyclic/chemical synthesis , Bridged Bicyclo Compounds, Heterocyclic/pharmacology , Organoselenium Compounds/chemical synthesis , Organoselenium Compounds/pharmacology , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/pharmacology , Antifungal Agents/chemical synthesis , Antifungal Agents/pharmacology , Antiviral Agents/chemical synthesis , Antiviral Agents/pharmacology , Azoles/chemical synthesis , Azoles/pharmacology , Bacteria/drug effects , Cell Survival , Fungi/drug effects , Humans , Indicators and Reagents , Isoindoles , Microbial Sensitivity Tests , Viruses/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...